Panu M. Jaakkola

Turku, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma.

Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma.

Journal: BJUI compass

Published: June 18, 2026

Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC.

Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC.

Journal: Theranostics

Published: May 28, 2025

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma.

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma.

Journal: BJUI compass

Published: January 27, 2025

Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.

Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.

Journal: British journal of cancer

Published: February 21, 2024

Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study.

Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study.

Journal: Cancers

Published: December 23, 2023

Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.

Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.

Journal: Cancer medicine

Published: October 30, 2023

Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial.

Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial.

Journal: Cell reports. Medicine

Published: April 19, 2023

Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy.

Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy.

Journal: Cancers

Published: November 27, 2021

Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.

Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 16, 2020

A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma.

A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma.

Journal: Scientific reports

Published: August 14, 2020

Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up.

Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up.

Journal: JAMA oncology

Published: May 30, 2020

Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma.

Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma.

Journal: The Journal of biological chemistry

Published: July 16, 2018

Showing 1-12 of 25

Last Updated: 09/26/2026